P/S SUNSTONE BIOMEDICINSK VENTURE III
Credit rating
Company information
About P/S SUNSTONE BIOMEDICINSK VENTURE III
P/S SUNSTONE BIOMEDICINSK VENTURE III (CVR number: 25884132) is a company from KØBENHAVN. The company recorded a gross profit of -450 kDKK in 2019. The operating profit was -450 kDKK, while net earnings were -14.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was -156.2 %, which can be considered poor and Return on Equity (ROE) was -156.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 75.3 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. P/S SUNSTONE BIOMEDICINSK VENTURE III's liquidity measured by quick ratio was 4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | 2017 | 2018 | 2019 | |
---|---|---|---|---|
Volume | ||||
Net sales | ||||
Gross profit | -5 494.00 | - 429.00 | - 822.00 | - 450.00 |
EBIT | -5 494.00 | - 429.00 | - 822.00 | - 450.00 |
Net earnings | -17 085.00 | 957.00 | 3 067.00 | -14 396.00 |
Shareholders equity total | 24 877.00 | 22 414.00 | 18 302.00 | 73.00 |
Balance sheet total (assets) | 24 903.00 | 22 436.00 | 18 327.00 | 97.00 |
Net debt | - 101.00 | -42.00 | - 124.00 | -97.00 |
Profitability | ||||
EBIT-% | ||||
ROA | -68.6 % | 4.1 % | 15.1 % | -156.2 % |
ROE | -68.7 % | 4.0 % | 15.1 % | -156.7 % |
ROI | -68.6 % | 4.1 % | 15.1 % | -156.7 % |
Economic value added (EVA) | -5 494.00 | -1 673.99 | -1 946.19 | -1 363.44 |
Solvency | ||||
Equity ratio | 99.9 % | 99.9 % | 99.9 % | 75.3 % |
Gearing | ||||
Relative net indebtedness % | ||||
Liquidity | ||||
Quick ratio | 957.8 | 1 019.8 | 733.1 | 4.0 |
Current ratio | 957.8 | 1 019.8 | 733.1 | 4.0 |
Cash and cash equivalents | 101.00 | 42.00 | 124.00 | 97.00 |
Capital use efficiency | ||||
Trade debtors turnover (days) | ||||
Net working capital % | ||||
Credit risk | ||||
Credit rating | B | B | B | C |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.